Rigel Pharmaceuticals
RIGL
#6819
Rank
โ‚น70.12 B
Marketcap
โ‚น3,724
Share price
-13.26%
Change (1 day)
21.62%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2023 (TTM): -โ‚น17.98

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น1,660. In 2022 the company made an earnings per share (EPS) of -โ‚น31.94 a decrease over its 2021 EPS that were of -โ‚น9.39.

EPS history for Rigel Pharmaceuticals from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น17.98-43.7%
2022-โ‚น31.94240%
2021-โ‚น9.39-37.5%
2020-โ‚น15.03-60%
2019-โ‚น37.57-11.11%
2018-โ‚น42.27-26.23%
2017-โ‚น57.30-17.57%
2016-โ‚น69.5125.42%
2015-โ‚น55.42-42.72%
2014-โ‚น96.751.98%
2013-โ‚น94.87-24.06%
2012-โ‚น124.92-4.32%
2011-โ‚น130.56-290.41%
2010โ‚น68.57-126.64%
2009-โ‚น257.36-25.14%
2008-โ‚น343.7741.86%
2007-โ‚น242.3370.86%
2006-โ‚น141.83-27.4%
2005-โ‚น195.37-33.33%
2004-โ‚น293.05-37.73%
2003-โ‚น470.59-31.83%
2002-โ‚น690.35-63.55%
2001-โ‚น1,894-96.43%
2000-โ‚น53,095

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
โ‚น1,524-8.21%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น627.44-62.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
-โ‚น35.69-102.15%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
-โ‚น177.52-110.70%๐Ÿ‡บ๐Ÿ‡ธ USA